HAYA Therapeutics
Business Services · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Route De La Corniche Batiment Alanine 5b...Website
www.hayatx.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About HAYA Therapeutics
HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health conditions associated with aging, including cancer. The company is headquartered in Lausanne, Switzerland.Explore more
HAYA Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HAYA Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on HAYA Therapeutics recently announced quarterly report
Check out if HAYA Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once HAYA Therapeutics has new funding data
Product Launch: Get notified when HAYA Therapeutics launches new products
Click to see if HAYA Therapeutics had a recent Job posting/layoffs
Check if HAYA Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at HAYA Therapeutics
HAYA Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at HAYA Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
HAYA Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
HAYA Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about HAYA Therapeutics.
HAYA Therapeutics financials insights
Gather financial insights about HAYA Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$25M
2025
Series A
$65M
HAYA Therapeutics Tech Stack
A closer look at the technologies used by HAYA Therapeutics
Most Recent Scoops
Open Position
Open Position
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Funding
Open Position
HAYA Therapeutics News & Media
HAYA Therapeutics to Present on RNA-Guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)-- #ASGCT--HAYA Therapeutics to Present on RNA-guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)-- #Exscientia--HAYA Therapeutics appoints former Exscientia executive Dr. Richard Law as Chief Business OfficerHAYA Therapeutics Awarded Innosuisse Certificate for Sustainable Growth and Funding to Advance Treatment for Aggressive Solid Tumors
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)-- #Cardiology--HAYA Therapeutics awarded Innosuisse Certificate for Sustainable Growth and funding to advance treatment for aggressive solid tumorsLatest Updates of Viva Biotech's Portfolio Companies
HONG KONG, Oct. 30, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, Viva Biotech's portfolio companies have new updates. Keep reading for more details. Seraxis Announces FDA IND Allowance for Clinical Study of SR-02 Replacement Islets
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding HAYA Therapeutics
Sign Up For FreeTo access detailed company insights
HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health conditions associated with aging, including cancer. The company is headquartered in Lausanne, Switzerland.... Read More
